Detección por citometría de flujo de la enfermedad mínima residual en las leucemias agudas

Translated title of the contribution: Detection of the minimal residual disease by flow cytometry in patients with acute leukemia

Ricardo Andrés Cardona Quiceno, Gladys Stella Mejía Pineda, Lucelly López López, Luis Felipe Álvarez Hernández, Camilo Ruiz Mejía, Laura Isabel Jaramillo Jaramillo, Juan Diego Villegas Álzate, Laura Herrera Almanza, Felipe Hernández Restrepo, Lina María Martínez Sánchez

    Research output: Contribution to journalArticle in an indexed scientific journalResearchpeer-review


    Introduction: The minimal residual disease is the permanence of residual leukemic cells at subclinical levels after remission of the disease. This condition increases the risk of relapse and mortality. Objective: To characterize the clinical and molecular factors of patients with acute leukemias and minimal residual disease detected by flow cytometry in a highly complex institution in the city of Medellín, Colombia during the years 2015-2017. Methodology: This is a retrospective descriptive observational study, which included patients with leukemia diagnosed by flow cytometry. A non-probabilistic sampling of consecutive cases was carried out. The information collected was entered into a database in Excel, and the analysis was carried out through the IBM SPSS Version 24 program, using absolute and relative frequencies, average and standard deviation or median and interquartile ranges, according to the nature of each variable and its distribution. Results: 60 patients were included in which male sex predominated with 63.3% (38). The most frequent diagnosis was lymphoid leukemia with 78.3% (47). Of the total patients included, 36.6% (22) were positive for minimal residual disease; 28.3% received a bone marrow transplant and 10% (6) had a cerebrospinal fluid compromise. In the second cytometry of the patients with minimal residual disease, 90.9% (20) expressed CD45 +. 31.8% (7) of the patients with minimal residual disease relapsed. Conclusion: Minimal residual disease is a frequent pathology in patients with acute leukemias that requires follow-up and constitutes a relevant prognostic factor.

    Translated title of the contributionDetection of the minimal residual disease by flow cytometry in patients with acute leukemia
    Original languageSpanish
    Article numbere1428
    JournalRevista Cubana de Hematologia, Inmunologia y Hemoterapia
    Issue number3
    StatePublished - 1 Jul 2021

    Bibliographical note

    Publisher Copyright:
    © 2021, Editorial Ciencias Medicas. All rights reserved.


    Dive into the research topics of 'Detection of the minimal residual disease by flow cytometry in patients with acute leukemia'. Together they form a unique fingerprint.

    Cite this